| Literature DB >> 31033496 |
Betty Glinsmann-Gibson1, Lee Wisner1, Melissa Stanton2, Brandon Larsen2, Lisa Rimsza2, Alanna Maguire1.
Abstract
Tissue microarrays (TMAs) are important tools to conserve precious tissue resources from increasingly smaller biopsies and to control experimental costs and variation across sample sets. The quality assurance assessment of TMA materials created at centralized biobanks has not been standardized. Herein, we outline 2 processes for the construction of TMAs ("recipient block" and "tape" methods) and the associated preconstruction quality control measures (pathology review, protein and RNA assessment, map creation, and storage conditions) developed by the AIDS Cancer Specimen Resource (ACSR) Network's Science and Technology Core. These steps provide a suggested framework for quality assessment that allows end-users, receiving materials from tissue banks, confidence in their experimental results.Entities:
Mesh:
Year: 2020 PMID: 31033496 PMCID: PMC6813869 DOI: 10.1097/PAI.0000000000000739
Source DB: PubMed Journal: Appl Immunohistochem Mol Morphol ISSN: 1533-4058